3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
11
Lung Neoplasms
8
Neoplasms
7
Prostatic Neoplasms
6
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Melanoma
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasm Metastasis
4
Hematologic Neoplasms
4
Esophageal Neoplasms
4
Multiple Myeloma
3
Carcinoma, Renal Cell
3
COVID-19
3
Barrett Esophagus
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Papillomavirus Infections
2
Ovarian Neoplasms
2
Leukemia, Myeloid, Acute
2
Genetic Predisposition to Disease
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Adenocarcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Interventions
Surveys and Questionnaires
2
Biopsy, Fine-Needle
2
Watchful Waiting
1
Ultrasonography
1
Tape Recording
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Reverse Transcriptase Polymerase Chain Reaction
1
Physical Examination
1
Interviews as Topic
1
In Situ Hybridization, Fluorescence
1
Gene Expression Profiling
1
Data Collection
1
Blood Specimen Collection
1
Amplified Fragment Length Polymorphism Analysis
1
4-amino-4'-hydroxylaminodiphenylsulfone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Uveal Melanoma
×
Specimen Handling
×
Clear all
NCT06861647
2026-04-01
iSITE
The Wellcome Sanger Institute
Completed
58 enrolled